Valuation : Formycon AG

Market Cap 345M 401M 324M 296M 557M 38.3B 559M 3.84B 1.5B 19.33B 1.5B 1.47B 64.11B P/E 2026 *
651x
P/E 2027 * 14.7x
Enterprise Value 460M 533M 431M 393M 741M 50.97B 743M 5.11B 1.99B 25.73B 2B 1.96B 85.31B EV / Sales 2026 *
6.32x
EV / Sales 2027 * 4.08x
Free-Float
70%
Yield 2026 *
-
Yield 2027 * -
1 day+1.23%
1 week+4.92%
Current month+5.58%
1 month+7.14%
3 months-4.93%
6 months-9.40%
Current year-20.90%
1 week 18.38
Extreme 18.38
20.25
1 month 18.02
Extreme 18.02
20.25
Current year 15.8
Extreme 15.8
26.95
1 year 15.8
Extreme 15.8
26.95
3 years 15.8
Extreme 15.8
67.8
5 years 15.8
Extreme 15.8
94.1
10 years 14.65
Extreme 14.65
94.1
Manager TitleAgeSince
Chief Executive Officer - 2022-06-30
Director of Finance/CFO 57 2023-03-31
Chief Tech/Sci/R&D Officer - 2022-06-30
Director TitleAgeSince
Director/Board Member 49 2020-12-09
Chairman 54 2024-06-11
Director/Board Member 54 2024-06-11
Date Insider Type Main position Quantity % Market Cap.
2/21/25 Buy

Chief Technology Officer

160 0.0009%
4/29/24 Buy

Executive/Senior Manager

1,200 0.0068%
4/24/24 Buy

Chief Executive Officer

2,500 0.0142%
Change 5-day change 1-year change 3-year change Capi.($)
+3.63%+4.92%-17.68%-66.69% 402M
-0.78%-1.42%+2.49%+22.78% 51.14B
-6.36%-1.46%+438.56%+539.82% 47.4B
-0.33%+0.34%+38.14%+17.55% 43.19B
-2.16%-2.49%+22.55%+80.68% 42.35B
-0.31%-1.75%+17.23%+52.37% 33.23B
-1.45%-2.72%+27.69%+130.80% 17.07B
-1.04%-2.37% - - 16.38B
-0.88%-0.66%+11.60%+27.75% 14.76B
-1.17%-1.06%+78.94%+46.95% 14.15B
Average -1.31%+1.10%+68.84%+94.67% 28.01B
Weighted average by Cap. -1.85%+1.12%+98.01%+136.32%

Financials

2026 *2027 *
Net sales 72.66M 84.32M 68.12M 62.19M 117M 8.06B 118M 808M 315M 4.07B 317M 310M 13.49B 112M 130M 105M 96.18M 181M 12.46B 182M 1.25B 488M 6.29B 490M 479M 20.86B
Net income 343K 398K 322K 294K 553K 38.04M 555K 3.82M 1.49M 19.2M 1.49M 1.46M 63.68M 23.19M 26.91M 21.74M 19.85M 37.39M 2.57B 37.51M 258M 101M 1.3B 101M 98.84M 4.31B
Net Debt 114M 133M 107M 97.74M 184M 12.67B 185M 1.27B 496M 6.39B 498M 487M 21.2B 113M 132M 106M 97.06M 183M 12.58B 183M 1.26B 492M 6.35B 494M 483M 21.05B
Logo Formycon AG
Formycon AG is a Germany based Company. The Company is engaged in providing biosimilar drugs and formulations. The Company focuses on treatments in ophthalmology, immunology and other chronic diseases, covering all steps of biosimilar development process, from early-stage analysis of the originator drug to the preclinical and clinical testing phases, as well as the preparation of dossiers for marketing approval.
Employees
196
Date Price Change Volume
26-08-28 20.25 +3.63% 5,897
26-08-27 €19.54 -1.81% 2,527
26-08-26 €19.90 +7.92% 10,617
26-08-25 €18.44 -4.65% 7,264
26-08-24 €19.34 +0.21% 2,147
Trader
Investor
-
Global
-
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
19.54EUR
Average target price
39.67EUR
Spread / Average Target
+103.00%

Quarterly revenue - Rate of surprise